» Articles » PMID: 33743609

The Role of MGlu4 Receptors Within the Nucleus Accumbens in Acquisition and Expression of Morphine-induced Conditioned Place Preference in Male Rats

Overview
Journal BMC Neurosci
Publisher Biomed Central
Specialty Neurology
Date 2021 Mar 21
PMID 33743609
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Several studies have shown that glutamate neurotransmission in the nucleus accumbens (NAc) is required for the development of morphine-induced conditional place preference (CPP). In addition, metabotropic glutamate receptors (mGluRs) in NAc play important roles in the reward pathways. However, the precise role of mGluR4 in different steps of the morphine-induced CPP is less well known. In the present study the effect of bilateral intra-accumbal infusion of VU0155041, as a specific mGluR4 agonist on the acquisition and expression of morphine induced CPP in male Wistar rats was investigated. The animals were bilaterally implanted with guide cannulae above the NAc. In the first step of the study, the VU0155041 was administered at doses of 10, 30 and 50 μg/0.5 μL saline per side into the NAc during the 3 days of morphine (5 mg/kg) conditioning (acquisition) phase of morphine-induced CPP. In the second step of the study, the rats bilaterally received VU0155041 at the dose of 50 μg/0.5 μL, 5 min before the post-conditioning test in order to check the effect of VU0155041 on the expression of morphine-induced CPP.

Results: The results showed that the intra-accumbal injection of VU0155041 inhibits the acquisition of morphine-induced CPP in a dose dependent manner, but had no effect on expression.

Conclusions: The data indicated that intra-NAc administration of VU0155041 dose dependently blocks the establishment of morphine-induced CPP and reduces the rewarding properties of morphine. These effects may be related to changes in glutamate activity in the NAC and/or learning dependent mechanism of glutamate neurotransmission in reward pathway(s).

Citing Articles

Effect of intrahippocampal microinjection of VU0155041, a positive allosteric modulator of mGluR4, on long term potentiation in a valproic acid-induced autistic male rat model.

Ebrahimi Z, Gholipour P, Mohammadkhani R, Ghahremani R, Sarihi A, Komaki A IBRO Neurosci Rep. 2024; 16:629-634.

PMID: 38832089 PMC: 11144792. DOI: 10.1016/j.ibneur.2024.05.005.

References
1.
Tzschentke T . Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol. 1999; 56(6):613-72. DOI: 10.1016/s0301-0082(98)00060-4. View

2.
Schoell A, Heyde B, Weir D, Chiang P, Hu Y, Tung D . Euthanasia method for mice in rapid time-course pulmonary pharmacokinetic studies. J Am Assoc Lab Anim Sci. 2009; 48(5):506-11. PMC: 2755020. View

3.
Swanson C, Bures M, Johnson M, Linden A, Monn J, Schoepp D . Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat Rev Drug Discov. 2005; 4(2):131-44. DOI: 10.1038/nrd1630. View

4.
Leshner A . Science is revolutionizing our view of addiction--and what to do about it. Am J Psychiatry. 1999; 156(1):1-3. DOI: 10.1176/ajp.156.1.1. View

5.
Berg K, Clarke W . Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity. Int J Neuropsychopharmacol. 2018; 21(10):962-977. PMC: 6165953. DOI: 10.1093/ijnp/pyy071. View